Brief Cognitive Behavioral Therapy for Anxiety
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03820973 |
Recruitment Status :
Recruiting
First Posted : January 29, 2019
Last Update Posted : February 21, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Anxiety | Behavioral: Brief CBT for Anxiety | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 16 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Development and Pilot Testing of Video-based Deliver of Brief Cognitive Behavioral Therapy for Anxiety |
Actual Study Start Date : | February 1, 2019 |
Estimated Primary Completion Date : | July 1, 2020 |
Estimated Study Completion Date : | September 1, 2020 |
Arm | Intervention/treatment |
---|---|
Experimental: Brief CBT for Anxiety
Participants will receive Brief Cognitive Behavioral Therapy for Anxiety (bCBT). Sessions with clinicians will be provided via VA Video Connect to Home (VVC-H). Participants will have the option to select from a list of skills to tailor to his/her preferences. Participants will be able to receive up to 9 total sessions and generally last 30 to 40 minutes. For the purpose of this study, treatment duration will be limited to 3 months to ensure standardization of study outcome measures.
|
Behavioral: Brief CBT for Anxiety
All participants will receive psychoeducation on anxiety and bCBT treatment approach, work on setting goals, begin self-monitoring, and select skill sessions that fit his/her most pressing needs. Available skills: Relaxation-Diaphragmatic breathing is a simple relaxation technique that increases oxygen flow and reduces the unpleasant physiological sensations associated with anxiety; Exposure - designed to educate Veterans about the role of avoidance in maintaining anxiety problems, as well as information about how to reduce avoidance through exposure exercises; Cognitive - Veterans may opt to address anxiety and worry through modifying negative thinking patterns. Two available options - Increasing Helpful Thoughts and Managing Unhelpful Thoughts. |
- Generalized Anxiety Disorder - 7 item scale - looking at change in scores over time [ Time Frame: Baseline, and 3-Months ]scale used to measure anxiety, scores range from 0 to 21, where higher scores equal higher levels of anxiety.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 99 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Veteran participants: The sample will include Veterans who:
- receive care at the Houston VA and surrounding area CBOCs,
- have documentation in the medical chart of an anxiety disorder or anxiety-related problems, and
- report clinically significant symptoms of anxiety, defined as a score of 10 or greater on the Generalized Anxiety Disorder Scale, 7th edition (GAD-7).
Exclusion Criteria:
Veteran participants will be excluded for factors that would render bCBT inappropriate, including:
- cognitive impairment;
- presence of bipolar, psychotic or substance use disorders, and
- Veteran is currently receiving psychotherapy for anxiety. If receiving medications that target anxiety Veterans WILL NOT be excluded.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03820973
Contact: Darrell Zeno, MS | 713-440-4492 | darrell.zeno@va.gov | |
Contact: Andrew Robinson, MA | 713-440-4400 ext 10262 | andrew.robinson@va.gov |
United States, Texas | |
Michael E. DeBakey VAMC | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Darrell Zeno, MS 713-440-4492 darrell.zeno@va.gov | |
Contact: Andrew Robinson, MA 713-440-4400 ext 10262 andrew.robinson@va.gov |
Principal Investigator: | Jeffrey Cully, PhD | Michael E. DeBakey VAMC |
Responsible Party: | Jeffrey Cully, Clinicial Research Psychologist, Michael Debakey Veterans Affairs Medical Center |
ClinicalTrials.gov Identifier: | NCT03820973 |
Other Study ID Numbers: |
H-44258 |
First Posted: | January 29, 2019 Key Record Dates |
Last Update Posted: | February 21, 2020 |
Last Verified: | February 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
brief Cognitive Behavioral Therapy VA Video Connect to home |
Anxiety Disorders Mental Disorders |